Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Moderate for sleep, Preliminary for weight — the sleep ingredients have randomized human support; the fat-burning half of the claim rests on inference, not trials
What Renew Claims To Be
Renew is marketed on a two-part proposition: improve deep sleep, and the improved sleep will restore your metabolism and drive fat burning overnight. It is sold in the weight loss category, but the ingredient list is unmistakably a sleep formula.
That link — sleep quality to body weight — is not fabricated. Short and fragmented sleep does associate with appetite dysregulation and weight gain in epidemiological work. But an association running from poor sleep to weight gain is not the same as a supplement that improves sleep producing weight loss. That second step is the one to watch.
What’s Actually In It
Renew’s disclosed ingredients:
- Ashwagandha (Withania somnifera)
- Griffonia simplicifolia (a 5-HTP source)
- L-theanine
- Melatonin
- Magnesium
- Zinc
- L-arginine
- L-lysine
Seven of these eight are sleep, relaxation, or general-nutrition ingredients. None is a thermogenic. The arginine and lysine pairing is the closest thing to a metabolic play — that combination has been studied for growth hormone response — but it is not a fat-burning mechanism in any conventional sense.
Amounts are not published. Melatonin dose in particular is worth knowing before you swallow anything, since effective doses are often far lower than what supplements contain.
What The Research Shows
According to PubMed, the sleep side of this formula has better backing than the weight side.
Ashwagandha has direct randomized support for sleep. In a double-blind, randomized, parallel-group, placebo-controlled study, 80 participants — 40 healthy, 40 with insomnia — took ashwagandha root extract or placebo for eight weeks. Sleep parameters improved significantly in the ashwagandha group, with the effect larger in the insomnia subjects. Sleep onset latency and sleep efficiency were the most improved measures (both p \< 0.0001), followed by total sleep time and wake after sleep onset, alongside significant improvements in anxiety scores and morning mental alertness. The extract was well tolerated across both groups. DOI
Melatonin-type agents help with falling asleep — but rank below prescription options. A systematic review and network meta-analysis of 69 randomized trials covering 17,319 adults with insomnia compared 20 medications. Melatonin receptor agonists “may also be efficacious for sleep-onset insomnia with good safety,” but orexin receptor antagonists outranked them on sleep latency, wake after sleep onset, total sleep time, and sleep efficiency. Melatonin’s niche is real but narrow: it is a sleep-onset aid, not a sleep-depth aid. DOI
And melatonin is not universally effective. A Cochrane review of pharmacotherapies for sleep disturbance in dementia found low-certainty evidence that melatonin at doses up to 10 mg may have little or no effect on any major sleep outcome over eight to ten weeks. Pooled total nocturnal sleep time differed by just 10.68 minutes versus placebo, with a confidence interval crossing zero. Single studies found no effect on sleep efficiency, time awake after sleep onset, or number of night-time awakenings. No serious adverse effects were reported. DOI
On weight, the evidence is simply absent. None of these trials measured body weight or fat mass as an outcome. The sleep-to-weight-loss chain in the marketing is an inference the research above does not test.
The Honest Verdict
What holds up: The sleep formulation is sensible and largely evidence-backed. Ashwagandha’s eight-week placebo-controlled trial is the strongest single piece of support here, and it measured exactly what the product promises to improve. Melatonin is genuinely useful for sleep onset with a good safety record. L-theanine and magnesium are reasonable, low-risk relaxation additions. As a bedtime supplement, this is a coherent stack rather than a random one.
What doesn’t: The weight loss framing, which is the entire reason the product is sold in that category. No trial cited here measured fat loss, and the “burns fat while you sleep” implication is not something the sleep literature supports. The Cochrane melatonin finding is a useful corrective to the assumption that melatonin reliably deepens sleep — it often does not. And undisclosed doses matter especially for melatonin and 5-HTP, where more is not better and interactions are real.
Who this makes sense for: Someone whose actual complaint is trouble falling asleep or feeling unrested, who would benefit from an ashwagandha-plus-melatonin bedtime formula and treats any weight change as an incidental possibility rather than the point. Better sleep is worth having on its own terms.
Who should skip it: Anyone buying this primarily to lose weight — the evidence for that is not here. Skip it too if you take SSRIs, SNRIs, MAO inhibitors, triptans, or tramadol, because 5-HTP raises serotonin and combining serotonergic agents carries genuine risk. Ashwagandha warrants caution with thyroid medication, immunosuppressants, and sedatives, and has been associated with rare liver injury reports. If your sleep problem is chronic, or you snore heavily and wake unrefreshed, sleep apnea screening is the right next step rather than a supplement.
Check current pricing and availability
View Renew on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed: